Comparison of Allogeneic vs Autologous Bone Marrow-Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy - POSEIDON

Description:

The goal of the trial was to evaluate transendocardial injection of allogeneic mesenchymal stem cells compared with autologous mesenchymal stem cells among patients with ischemic cardiomyopathy.